Buyer overview

AOK Bayern - Die Gesundheitskasse

Germany

Find open notices with exactly the same buyer name and country.

Open notices in this group

64
Open TED DEU

Germany · Medical equipment, pharmaceuticals and personal care products

Official title · Deutsch

Open house Arzneimittelrabattverträge Flupentixol, ATC N05AF01

AOK Bayern - Die Gesundheitskasse

The official notice does not provide a concise description in this language.

Deadline
Oct 3, 2028 12:00 UTC+02:00
Estimated value
Not announced
Open TED DEU

Germany · Medical equipment, pharmaceuticals and personal care products

Official title · Deutsch

Open house Arzneimittelrabattverträge Rituximab, ATC L01FA01

AOK Bayern - Die Gesundheitskasse

The official notice does not provide a concise description in this language.

Deadline
Oct 3, 2028 12:00 UTC+02:00
Estimated value
Not announced
Open TED DEU

Germany · Medical equipment, pharmaceuticals and personal care products

Official title · Deutsch

Open house Arzneimittelrabattverträge Teduglutid, ATC A16AX08

AOK Bayern - Die Gesundheitskasse

The official notice does not provide a concise description in this language.

Deadline
Oct 3, 2028 12:00 UTC+02:00
Estimated value
Not announced

Retained publications

The 20 most recent publications retained in Tenderiva, including open notices. This history is partial: a publication does not necessarily represent a distinct or awarded contract.

  1. Competition noticeTED

    Open house Arzneimittelrabattverträge Indacaterol und Glycopyrroniumbromid, ATC R03AL04

    714694-2026
  2. Competition noticeTED

    Open house Arzneimittelrabattverträge Teduglutid, ATC A16AX08

    714284-2026
  3. Competition noticeTED

    Open house Arzneimittelrabattverträge Rituximab, ATC L01FA01

    714205-2026
  4. Competition noticeTED

    Open house Arzneimittelrabattverträge Flupentixol, ATC N05AF01

    713987-2026
  5. Competition noticeTED

    Open house Arzneimittelrabattverträge Melatonin, ausgenommen Retardtabletten in der Wirkstärke 2mg, ATC N05CH01

    713168-2026
  6. Competition noticeTED

    Open house Arzneimittelrabattverträge Pridinol, ATC M03BX03

    712813-2026
  7. Competition noticeTED

    Open house Arzneimittelrabattverträge Apixaban, ATC B01AF02

    712581-2026
  8. Competition noticeTED

    Open house Arzneimittelrabattverträge Chlortalidon, ATC C03BA04

    711430-2026
  9. Competition noticeTED

    Open house Arzneimittelrabattverträge Trastuzumab, zur subkutanen Anwendung, ATC L01FD01

    711308-2026
  10. Competition noticeTED

    Vertrag über Callcenter-Leistungen zur Versichertenkommunikation Versorgungsverträge

    710041-2026
  11. Competition noticeTED

    Videosprechstunde

    670951-2026
  12. Competition noticeTED

    Open house Arzneimittelrabattverträge Rasagilin, ATC N04BD02

    632536-2026
  13. Competition noticeTED

    Open house Arzneimittelrabattverträge Testosteron, ausgenommen in der Darreichungsform Injektionslösung, ATC G03BA03

    632344-2026
  14. Competition noticeTED

    Open house Arzneimittelrabattverträge Epinephrin, ausgenommen in der nasalen Darreichungsform, ATC C01CA24

    632328-2026
  15. Competition noticeTED

    Open house Arzneimittelrabattverträge Naproxen, ATC M01AE02

    632270-2026
  16. Competition noticeTED

    Open house Arzneimittelrabattverträge Lopinavir und Ritonavir, ATC J05AR10

    632165-2026
  17. Competition noticeTED

    Open house Arzneimittelrabattverträge Infliximab, ausgenommen in der Wirkstärke 120mg, ATC L04AB02

    632034-2026
  18. Competition noticeTED

    Open house Arzneimittelrabattverträge Infliximab, in der Wirkstärke 120mg, ATC L04AB02

    631890-2026
  19. Competition noticeTED

    Open house Arzneimittelrabattverträge Sarilumab, ATC L04AC14

    631617-2026
  20. Competition noticeTED

    Open house Arzneimittelrabattverträge Aprepitant, Fosaprepitant, ATC A04AD12

    631613-2026